Your browser is no longer supported. Please, upgrade your browser.
ImmuCell Corporation
Index- P/E- EPS (ttm)-0.19 Insider Own0.10% Shs Outstand7.22M Perf Week-3.50%
Market Cap71.22M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float5.52M Perf Month3.88%
Income-1.30M PEG- EPS next Q0.05 Inst Own9.50% Short Float0.23% Perf Quarter-11.63%
Sales14.50M P/S4.91 EPS this Y25.40% Inst Trans-0.14% Short Ratio0.55 Perf Half Y71.40%
Book/sh3.86 P/B2.50 EPS next Y- ROA-3.30% Target Price- Perf Year137.69%
Cash/sh- P/C- EPS next 5Y- ROE-4.80% 52W Range3.80 - 13.20 Perf YTD62.19%
Dividend- P/FCF- EPS past 5Y-18.70% ROI-1.40% 52W High-26.89% Beta0.95
Dividend %- Quick Ratio4.60 Sales past 5Y8.40% Gross Margin42.80% 52W Low153.94% ATR0.64
Employees61 Current Ratio5.60 Sales Q/Q-16.30% Oper. Margin-13.70% RSI (14)47.71 Volatility6.71% 6.83%
OptionableNo Debt/Eq0.33 EPS Q/Q-260.60% Profit Margin-9.20% Rel Volume0.79 Prev Close9.21
ShortableYes LT Debt/Eq0.30 EarningsMay 13 AMC Payout- Avg Volume22.85K Price9.65
Recom2.00 SMA20-2.48% SMA50-2.51% SMA20030.17% Volume17,942 Change4.78%
May-14-21 07:15AM  
May-13-21 04:05PM  
May-06-21 01:41PM  
Apr-19-21 04:53AM  
Apr-14-21 05:15PM  
Apr-07-21 08:00AM  
Feb-23-21 07:15AM  
Feb-22-21 04:03PM  
Feb-16-21 01:42PM  
Jan-07-21 08:00AM  
Dec-15-20 04:05PM  
Nov-12-20 04:05PM  
Nov-05-20 02:10PM  
Oct-19-20 12:35PM  
Oct-06-20 08:00AM  
Aug-12-20 04:05PM  
Aug-06-20 08:00AM  
Jul-07-20 08:00AM  
Jun-16-20 08:00AM  
May-18-20 11:48AM  
May-14-20 01:35PM  
May-13-20 04:05PM  
May-07-20 12:00PM  
Apr-20-20 10:52AM  
Apr-14-20 08:00AM  
Apr-03-20 07:36AM  
Apr-02-20 04:29PM  
Mar-11-20 04:05PM  
Mar-01-20 09:09AM  
Feb-26-20 01:09AM  
Feb-19-20 12:35PM  
Feb-18-20 04:05PM  
Feb-13-20 09:17AM  
Jan-24-20 12:04PM  
Jan-21-20 12:30PM  
Jan-06-20 02:25PM  
Dec-22-19 01:21PM  
Dec-19-19 11:38AM  
Nov-12-19 09:37AM  
Nov-11-19 04:05PM  
Nov-05-19 08:00AM  
Sep-17-19 08:00AM  
Sep-11-19 08:00AM  
Sep-06-19 11:43PM  
Aug-29-19 08:00AM  
Aug-12-19 04:05PM  
Aug-11-19 03:46PM  
Aug-06-19 08:00AM  
May-21-19 11:20AM  
May-14-19 07:42AM  
May-13-19 04:05PM  
May-07-19 09:00AM  
Mar-29-19 11:45AM  
Mar-27-19 07:30AM  
Mar-26-19 04:10PM  
Mar-22-19 10:48AM  
Mar-07-19 02:04PM  
Feb-28-19 02:00PM  
Feb-14-19 07:50AM  
Feb-13-19 04:05PM  
Feb-06-19 09:27AM  
Jan-11-19 02:00PM  
Dec-11-18 08:00AM  
Nov-23-18 08:00AM  
Nov-13-18 04:05PM  
Nov-08-18 08:00AM  
Nov-07-18 09:16AM  
Sep-26-18 03:25PM  
Sep-25-18 04:16PM  
Aug-30-18 11:02AM  
Aug-14-18 07:00AM  
Aug-13-18 04:05PM  
Aug-07-18 10:30AM  
Jul-25-18 06:30AM  
Jul-10-18 06:30AM  
Jun-25-18 06:30AM  
Jun-07-18 02:02PM  
May-23-18 12:03PM  
May-22-18 07:20AM  
May-14-18 04:05PM  
May-07-18 11:00AM  
Apr-11-18 02:07PM  
Mar-05-18 07:55PM  
Feb-12-18 07:16AM  
Feb-08-18 04:05PM  
Feb-05-18 05:10PM  
Jan-30-18 06:30AM  
Dec-25-17 09:31AM  
Dec-21-17 11:00AM  
Dec-19-17 06:30AM  
Nov-22-17 02:48PM  
Nov-13-17 04:05PM  
Nov-07-17 06:30AM  
ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. The company sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.